| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8234104 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 4 Pages |
Abstract
Concurrent chemotherapy improves the therapeutic index for radiation of HNSCC. Further refinements are needed in quantifying the therapeutic gain attributable to specific radiosensitizing agents in clinical trials, notably better and more consistent reporting of treatment sequelae.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Irwin H. M.D., Ph.D., Avraham M.D.,